An NF-κB-dependent role for JunB in the induction of proinflammatory cytokines in LPS-activated bone marrow-derived dendritic cells

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Gomard, Tiphanie ^a,b   Michaud, Henri Alexandre ^a,b   Tempé, Denis ^a,b   Thiolon, Kevin ^a,b   Pelegrin, Mireia ^a,b   Piechaczyk, Marc ^a,b  

^a CNRS   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR JUND; TUMOR NECROSIS FACTOR ALPHA; I KAPPA B KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; B LYMPHOCYTE; CELL STIMULATION; CHROMATIN IMMUNOPRECIPITATION; CYTOKINE PRODUCTION; DENDRITIC CELL; ESCHERICHIA COLI; FLOW CYTOMETRY; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION INITIATION; ANIMAL; BONE MARROW CELL; CHROMATIN; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; INFLAMMATION; METABOLISM; METHODOLOGY;

ESCHERICHIA COLI;

ANIMALS; BONE MARROW CELLS; CHROMATIN; DENDRITIC CELLS; ESCHERICHIA COLI; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; I-KAPPA B KINASE; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

EID: 77949661217     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009585     Document Type: Article

References (52)

1. Granucci F, Foti M, Ricciardi-Castagnoli P (2005) Dendritic cell biology. Adv Immunol 88: 193-233.
2. Reis e Sousa C (2006) Dendritic cells in a mature age. Nat Rev Immunol 476-483.
3. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21: 335-376.
4. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
5. Lu Y-C, Yeh W-C, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151.
6. O'Neill LAJ (2008) When signaling pathways collide: positive and negative regulation of Toll-like receptor signal transduction. Immunity 29: 12-20.
7. Jenner RG, Young RA (2005) Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol 3: 281-294.
8. Roach JC, Smith KD, Strobe KL, Nissen SM, Haudenschild CD, et al. (2007) Transcription factor expression in lipopolysaccharide-activated peripheral-blood-derived mononuclear cells. Proc Natl Acad Sci U S A 104: 16245-16250.
9. Shen H, Tesar BM, Walker WE, Goldstein DR (2008) Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation. J Immunol 181: 1849-1858.
10. Chinenov Y, Kerppola TK (2001) Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20: 2438-2452.
11. Vinson C, Acharya A, Taparowsky EJ (2006) Deciphering B-ZIP transcription factor interactions in vitro and in vivo. Biochim Biophys Acta 1759: 4-12.
12. Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868.
13. Hess J, Angel P, Schorpp-Kistner M (2004) AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 117: 5965-5973.
14. Wagner EF, Eferl R (2005) Fos/AP-1 proteins in bone and the immune system. Immunol Rev 208: 126-140.
15. Monje P, Hernandez-Losa J, Lyons RJ, Castellone MD, Gutkind JS (2005) Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J Biol Chem 280: 35081-35084.
16. Bossis G, Malnou CE, Farras R, Andermarcher E, Hipskind R, et al. (2005) Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol 25: 6964-6979.
17. Muller S, Berger M, Lehembre F, Seeler JS, Haupt Y, et al. (2000) c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem 275: 13321-13329.
18. Fujioka S, Niu J, Schmidt C, Sclabas GM, Peng B, et al. (2004) NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity. Mol Cell Biol 24: 7806-7819.
19. Krappmann D, Wegener E, Sunami Y, Esen M, Thiel A, et al. (2004) The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. Mol Cell Biol 24: 6488-6500.
20. Casals C, Barrachina M, Serra M, Lloberas J, Celada A (2007) Lipopolysaccharide up-regulates MHC class II expression on dendritic cells through an AP-1 enhancer without affecting the levels of CIITA. J Immunol 178: 6307-6315.
21. Dillon S, Agrawal A, Van Dyke T, Landreth G, McCauley L, et al. (2004) A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 172: 4733-4743.
22. Koga K, Takaesu G, Yoshida R, Nakaya M, Kobayashi T, et al. (2009) Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c-Fos protein. Immunity 30: 372-383.
23. Mann J, Oakley F, Johnson PW, Mann DA (2002) CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, AND CBF1. J Biol Chem 277: 17125-17138.
24. Mizumoto N, Hui F, Edelbaum D, Weil MR, Wren JD, et al. (2005) Differential activation profiles of multiple transcription factors during dendritic cell maturation. J Invest Dermatol 124: 718-724.
25. Fujihara M, Ikebuchi K, Maekawa TL, Wakamoto S, Ogiso C, et al. (1998) Lipopolysaccharide-induced desensitization of junB gene expression in a mouse macrophage-like cell line, P388D1. J Immunol 161: 3659-3665.
26. Florin L, Knebel J, Zigrino P, Vonderstrass B, Mauch C, et al. (2006) Delayed wound healing and epidermal hyperproliferation in mice lacking JunB in the skin. J Invest Dermatol 126: 902-911.
27. Garaude J, Farras R, Bossis G, Charni S, Piechaczyk M, et al. (2008) SUMOylation regulates the transcriptional activity of JunB in T lymphocytes. J Immunol 180: 5983-5990.
28. Hartenstein B, Teurich S, Hess J, Schenkel J, Schorpp-Kistner M, et al. (2002) Th2 cell-specific cytokine expression and allergen-induced airway inflammation depend on JunB. Embo J 21: 6321-6329.
29. Li B, Tournier C, Davis RJ, Flavell RA (1999) Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. Embo J 18: 420-432.
30. Meixner A, Zenz R, Schonthaler HB, Kenner L, Scheuch H, et al. (2008) Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation. Nat Cell Biol 10: 1003-1011.
31. Schmidt D, Textor B, Pein OT, Licht AH, Andrecht S, et al. (2007) Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis. Embo J 26: 710-719.
32. Szabowski A, Maas-Szabowski N, Andrecht S, Kolbus A, Schorpp-Kistner M, et al. (2000) c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 103: 745-755.
33. Textor B, Licht AH, Tuckermann JP, Jessberger R, Razin E, et al. (2007) JunB is required for IgE-mediated degranulation and cytokine release of mast cells. J Immunol 179: 6873-6880.
34. Kaisho T, Tanaka T (2008) Turning NF-kappaB and IRFs on and off in DC. Trends Immunol 29: 329-336.
35. Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, et al. (1997) Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 185: 317-328.
36. Basbous J, Chalbos D, Hipskind R, Jariel-Encontre I, Piechaczyk M (2007) Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer. Mol Cell Biol 27: 3936-3950.
37. Farras R, Baldin V, Gallach S, Acquaviva C, Bossis G, et al. (2008) JunB breakdown in mid-/late G2 is required for down-regulation of cyclin A2 levels and proper mitosis. Mol Cell Biol 28: 4173-4187.
38. Malnou CE, Brockly F, Favard C, Moquet-Torcy G, Piechaczyk M, et al. (2010) Heterodimerization with different Jun proteins controls c-Fos intranuclear dynamics and distribution. J Biol Chem.
39. Malnou CE, Salem T, Brockly F, Wodrich H, Piechaczyk M, et al. (2007) Heterodimerization with Jun family members regulates c-Fos nucleocytoplasmic traffic. J Biol Chem 282: 31046-31059.
40. Treier M, Staszewski LM, Bohmann D (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78: 787-798.
41. Hu X, Janssen WE, Moscinski LC, Bryington M, Dangsupa A, et al. (2001) An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism. Cancer Res 61: 6290-6296.
42. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, et al. (1997) Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272: 21096-21103.
43. Scaife CL, Kuang J, Wills JC, Trowbridge DB, Gray P, et al. (2002) Nuclear factor kappaB inhibitors induce adhesion-dependent colon cancer apoptosis: implications for metastasis. Cancer Res 62: 6870-6878.
44. Baccam M, Woo SY, Vinson C, Bishop GA (2003) CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP. J Immunol 170: 3099-3108.
45. Yao J, Mackman N, Edgington TS, Fan ST (1997) Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem 272: 17795-17801.
46. Zagariya A, Mungre S, Lovis R, Birrer M, Ness S, et al. (1998) Tumor necrosis factor alpha gene regulation: enhancement of C/EBPbeta-induced activation by c-Jun. Mol Cell Biol 18: 2815-2824.
47. Zhu C, Gagnidze K, Gemberling JH, Plevy SE (2001) Characterization of an activation protein-1-binding site in the murine interleukin-12 p40 promoter. Demonstration of novel functional elements by a reductionist approach. J Biol Chem 276: 18519-18528.
48. Brown RT, Ades IZ, Nordan RP (1995) An acute phase response factor/NF-kappa B site downstream of the junB gene that mediates responsiveness to interleukin-6 in a murine plasmacytoma. J Biol Chem 270: 31129-31135.
49. Frazier-Jessen MR, Thompson CD, Brown R, Rawat R, Nordan RP, et al. (2002) NF-kappaB elements contribute to junB inducibility by lipopolysaccharide in the murine macrophage cell line RAW264.7. FEBS Lett 513: 203-207.
50. Shen Z, Reznikoff G, Dranoff G, Rock KL (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158: 2723-2730.
51. Aida M, Chen Y, Nakajima K, Yamaguchi Y, Wada T, et al. (2006) Transcriptional pausing caused by NELF plays a dual role in regulating immediate-early expression of the junB gene. Mol Cell Biol 26: 6094-6104.
52. Andrecht S, Kolbus A, Hartenstein B, Angel P, Schorpp-Kistner M (2002) Cell cycle promoting activity of JunB through cyclin A activation. J Biol Chem 277: 35961-35968.